Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.8/5
Genscript Biotech (1548 HK)
Watchlist
Contact IR
79
Analysis
Health Care
•
Hong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Legend Biotech Corp
•
15 Oct 2024 00:55
Legend Biotech (LEGN.US) Offer Update - Is the Deal Really Dead?
Given the geopolitical risks, this acquisition is worth considering for both Legend Bio and Genscript. However, the main obstacles are disagreement...
Xinyao (Criss) Wang
Follow
884 Views
Share
bullish
•
Cross Asset Strategy
•
29 Sep 2024 23:22
Technically Speaking, Breakouts and Breakdowns: HONG KONG (SEPTEMBER 30)
Hong Kong dollar strengthens to the strong end of the band. Hengan and Galaxy share prices have both broken out of Falling Wedge patterns. Wuxi...
David Mudd
Follow
215 Views
Share
bullish
•
Legend Biotech Corp
•
03 Sep 2024 00:55
Legend Biotech (LEGN.US) Offer Update - The Takeover Negotiations Could Reach an Impasse?
Rumors swirl around acquisition price disagreement between Legend Bio and Genscrip. Deal has 50-50 chance of success. Investors still benefit if...
Xinyao (Criss) Wang
Follow
1.2k Views
Share
bullish
•
Anta Sports Products
•
01 Sep 2024 08:13
HK Connect SOUTHBOUND Flows (To 30 Aug 2024); Weak Econ Data, But a Rebound in SB Net Buys
SOUTHBOUND Connect flows picked up to the positive side again after the buy streak was broken the week before. Gross flows picked up. Econ data was...
Travis Lundy
Follow
443 Views
Share
bullish
•
Tencent
•
03 Aug 2024 13:49
HK Connect SOUTHBOUND Flows (To 2 Aug 2024); ETFs Get Sold; Tencent, SOEs, Utilities Bought
SOUTHBOUND flows for HK Connect were to the net buy side for the 26th week in a row. SOEs in Energy, Telcos, and Utilities were strong. Banks too....
Travis Lundy
Follow
512 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x